TATAA Biocenter, Basepair Partner
News Sep 20, 2016
TATAA Biocenter has partnered with Basepair to offer a significantly faster and easier-to-use tool for commercial and academic projects. As part of the partnership, TATAA Biocenter will offer its customers a seamlessly integrated online portal on https://tataa.basepairtech.com as an important component of its overall solution set. TATAA will also use Basepair’s software in its popular NGS training courses.
“Probably the biggest bottleneck our NGS customers and students run into is data analysis and interpretation. Waiting a day -- or even longer -- to get results just isn’t an option for many of them. So having a partner like Basepair whose software can process the analysis in about an hour was a great fit for our business,” said Mikael Kubista, President of TATAA Biocenter.
“We also appreciate the fact that the user does not have to be a computer scientist or bioinfomatician to run the analysis -- the intuitive user interface means that anyone can do it with just a couple clicks. There are even multiple built-in workflows.”
"We’re always looking to partner with innovative companies that are true leaders in the genomic
services industry, and TATAA Biocenter is exactly that. There is great synergy between their
customers’ and students’ NGS data analysis needs and our software’s ability to make the
analysis as easy as booking a flight online,” said Dr. Amit Sinha, Founder and CEO of Basepair.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections. Now, a new machine learning technique will help predict the risk of developing a serious, and possibly life-threatening S. epidermidis infection.READ MORE
Children who are genetically predisposed to overweight, due to common gene variants, can still lose weight by changing their diet and exercise habits. Around 750 children and adolescents with overweight or obesity undergoing lifestyle intervention participated in the study conducted by researchers from the University of Copenhagen and Holbæk Hospital.